gatifloxacin has been researched along with Sarcoma, Epithelioid in 1 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Excerpt | Relevance | Reference |
---|---|---|
"Patients with breast cancer or sarcoma who presented with fever and neutropenia and were identified as low risk received empiric, oral, quinolone monotherapy (gatifloxacin at a dose of 400 mg once daily)." | 3.73 | Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rules. ( Benjamin, RS; Elting, LS; Frisbee-Hume, SE; Manzullo, EF; McMahon, L; Patel, S; Rolston, KV; Theriault, RL, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rolston, KV | 1 |
Manzullo, EF | 1 |
Elting, LS | 1 |
Frisbee-Hume, SE | 1 |
McMahon, L | 1 |
Theriault, RL | 1 |
Patel, S | 1 |
Benjamin, RS | 1 |
1 other study available for gatifloxacin and Sarcoma, Epithelioid
Article | Year |
---|---|
Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rules.
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Anti-Bacterial Agents; Breast Neoplasms; Feasibi | 2006 |